MedGene Therapeutics, Inc. jobs and careers
Silver Spring, MD, United States
About MedGene Therapeutics, Inc.
MedGene Therapeutics is focused on developing ACT treatments (PMBC derived tumor-reactive T cells-Natural Unmodified CD8+ lymphocytes) for two cancers—MSTS (metastatic soft tissue sarcoma) and MFTC (metastatic follicular thyroid cancer)—using NIH patented technology with Worldwide Exclusive License Agreement of commercialization.
Founded in 2015 by Yong H Park.
- Founded
- 2015
- Employees
- 1 to 10
- Total funding
- $1.2M
- Headquarters
- Silver Spring
Leadership
The top of MedGene Therapeutics, Inc.'s org chart, with how many people report into each leader.
Yong H. Park
CEO
3 reports
Robin E. Fontenot
VP, Strategic Development
Steve Yoo
CFO
Yong W. Moon
Chief Medical Officer
Board
Young Jae Ryu
Advisor
James Song
Advisor
Rho H. Seong
Scientific Co-Founder
Eu Chang Hwang
Advisor
Jobs at MedGene Therapeutics, Inc.
No open positions right now. Explore more companies on TheJobsMap.